Introduction

If you’re passionate about making a difference in the lives of patients suffering from serious illnesses, your next career opportunity could be with Amgen Australia.

We are a diverse team of committed and accomplished people, working to advance the company’s global efforts to transform the promise of science and biotechnology into therapies that restore health and save lives.

Amgen Australia is an Equal Employment Opportunity / Affirmative Action employer striving to promote a high-performance, team-based environment where talent is embraced, innovative thinking is encouraged, and where helping employees reach their full potential is an integral part of our success.

We also share a desire to support the communities we serve by inspiring the next generation of scientists, giving our time to worthwhile causes and promoting environmental sustainability.

To keep up-to-date with career opportunities at Amgen Australia, create a profile in the Amgen Talent Community.

SPECIAL ADVISORY: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website or contact Amgen on 02 9870 1333 before applying. Additionally, please report any suspicious recruiting activity in Australia to Scamwatch. Thank you for your assistance.

News

Delivering Value to Customers Through Amgen One

The Amgen One Scientific Symposium is Amgen Australia’s flagship medical education event.

Created over 17 years ago as a meeting for Nephrologists, the Amgen Nephrology Scientific Symposium expanded in 2014 to incorporate a ‘Bone Academy’ stream for Endocrinologists, Rheumatologists and Geriatricians. In 2016, Cardiologists joined the meeting for the first time, following the introduction of a ‘Cardiovascular Academy’ stream and in 2019 the meeting continued to evolve with the addition of a ‘Myeloma Forum’.

The event now brings together over 300 delegates for the primary purpose of providing high-level scientific exchange and unique opportunities for cross-specialty education.

Independent steering committees made up of clinical experts from around Australia drive the development of the program and ensure the meeting is almost entirely dedicated to evidence-based medicine.

Renowned for scientific quality and clinical relevance, Amgen Australia is very proud of this event and the value it brings to our key customers.

 

Finding the 1.36 Million Australians at High Risk of Osteoporotic Fracture

While post-menopausal women are knowledgeable about osteoporosis, they rarely see themselves as being at risk and can be complacent about screening.

Unlike the perceived risk of cancer (a.k.a. ‘The Big C’), osteoporosis hasn’t traditionally been given the same focus, despite being more common than breast and cervical cancer combined.

Launched in 2019, Amgen Australia’s ‘The Big O’ campaign was designed to unearth some of the more than 450,000 Australians living with undiagnosed osteoporosis and therefore at risk of fractures that may ultimately contribute to loss of mobility and independence.

In a first for Amgen Australia, it included television advertising, media partnerships and a range of assets for online and social media channels as well as materials for GP surgeries and pharmacies.

Amgen is also fortunate to be working with Ita Buttrose AC OBE as the national ambassador for the campaign.

For World Osteoporosis Day in 2019, Ms. Buttrose hosted a large-scale event at Westfield Parramatta, including a panel discussion with leading media personalities and osteoporosis patients, and her involvement in helping raise awareness of the disease continues.

‘The Big O’ campaign has successfully highlighted the impact of osteoporosis and the importance of action to improve diagnosis and treatment. For more information about the condition and the need for bone density scanning, visit https://thebigo.com.au/

 

Amgen Army Out in Force for Day of Service

At Amgen, giving back to the communities where we live and work is part of our DNA.

That’s why, when we ran our first Annual Day of Service – an opportunity for Amgen Australia staff to collectively make a meaningful difference by contributing to causes that need a helping hand – a veritable army of volunteers turned out.

For many years, Amgen Australia has offered a two-day paid charity leave program to all permanent staff so that they can give their time to organisations and initiatives close to their heart. In 2019 however, rather than volunteering individually, the company’s Community Impact Team created an occasion where the whole company could come together in the service of others.

On Thursday 31st October, 15 different volunteering opportunities were organised all around Australia and staff could select an activity of their choice. From visiting the elderly, to working with people with disabilities, to gardening and bush regeneration, to preparing meals for those in need, over 150 employees donned an Amgen blue shirt and “rolled up their sleeves” to do their part.

In total, staff contributed more than 700 hours of help and support to people and organisations in need and, as an added bonus, working to create this positive change left our employees truly inspired and uplifted.

Amgen Australia’s support for the community and culture of caring are a great source of pride for our business and are some of the key reasons our employees regard Amgen as a great place to work.

To see highlights from the inaugural Annual Day of Service, please watch this video.

 

Supporting the ‘Kosi Challenge’ for Rare Cancers Australia

At 2,228m above sea level, the view from the top of Mount Kosciuszko is enough to take your breath away, as is the physically demanding trek from Valley Terminal in Thredbo to the summit!

For the last eight years however, teams from across Australia’s pharmaceutical industry have scaled our nation’s highest peak for Rare Cancers Australia’s (RCA) Kosi Challenge and Amgen has been proud to be among them.

Traversing the 17 kilometres of rocky slopes and mountain trails, the Amgen employees, together with their families and friends, enjoyed the stunning natural beauty of the area and the satisfaction of reaching the top.

Adding to the physical achievement, the teams raised vital funds to help RCA in their work to ensure rare cancer patients can access the same excellent care as those with more common cancers.

Each year, an estimated 52,000 Australians are diagnosed with rare or less common cancers and RCA works to provide them with information and support, foster a patient community and fundraise for treatment and essential research. The organisation also campaigns for equitable access to life-saving medicines.

100 percent of the funds raised through The Kosi Challenge go towards improving the outcomes for Australians living with a rare or less common cancer and Amgen Australia is proud to have contributed to this worthwhile cause.

 

Budding Scientists Benefit from Amgen Biotech Experience

In September 2019, Federal Member for Macarthur, Dr Mike Freelander, joined young scientists at John Therry Catholic High School participating in the Amgen Biotech Experience (ABE) – an innovative science education program that offers high school students hands-on biotech lab experience.

The ABE is an in-class initiative providing intensive professional development for teachers as well as teaching materials and research-grade equipment to classrooms to help educate students about the concepts and techniques scientists use to discover and develop medicines. Launched in Australia in 2017 through a partnership between The Amgen Foundation and The University of Sydney, the program is offered to schools at no cost and provides valuable learning opportunities.

Year 10 science students at John Therry Catholic High School took part in the program that has already reached over 3,000 students and is on track to engage a total of 5,000 students and 60 teachers in New South Wales in its first three years.

Recognising those connected with the program, Dr Freelander said, “It’s a great pleasure to see students participating in evidence-based programs like the Amgen Biotech Experience and I commend all those involved for making it available in our local area.

“As a paediatrician, a father of six and a Member of Parliament, I’m passionate about giving kids the best possible start in life, particularly through healthcare and education. While Governments are investing in improving STEM education, lifting student engagement and attainment is a massive task, so it’s wonderful that healthcare companies like Amgen are committing themselves to supporting teachers and students in these subjects and helping inspire the scientists of tomorrow,” he said.

The Amgen Biotech Experience has empowered teachers to bring biotechnology into their classrooms for more than 30 years. With leadership from university and other partners in each region, the program currently operates in Australia, Canada, France, Germany, Hong Kong SAR, Ireland, Italy, Netherlands, Puerto Rico, Singapore, United Kingdom and United States. To date, the Amgen Foundation has committed more than US$25 million to deliver the program globally to approximately 700,000 students, with over 88,000 students and 1,500 science teachers now participating annually.

To learn more about the ABE, visit AmgenBiotechExperience.com. To learn more about the Amgen Foundation’s other science education programs, visit AmgenInspires.com.

 

Amgen Recognised at Australian Packaging Covenant Awards

In November 2019, the businesses leading the way in sustainable packaging design and innovation were recognised at the Australian Packaging Covenant Organisation (APCO) Awards and Amgen Australia was among the winners.

APCO encourages businesses to design and utilise more sustainable packaging throughout their supply chains. Amgen Australia has voluntarily signed the Covenant, highlighting the company’s commitment to reducing our environmental impact and creating opportunities for employees who are passionate about sustainability to work with global experts and contribute to improvements in this area.

The APCO’s annual awards recognise those organisations that go above and beyond in this regard and celebrate important steps on the journey toward a circular economy for packaging.

At the ceremony in Melbourne, Amgen Australia proudly took out the top prize in the Pharmaceuticals category for the second consecutive year and was also awarded an overarching award for Outstanding Achievement in Sustainable Packaging Solutions, beating 33 nominees across industry sectors ranging from food and beverage to telecommunications to agriculture.

Amgen is committed to environmentally sound practices and is working to improve sustainability along the entire life cycle of our products, including in research, development, manufacturing, packaging, and disposal.

The company’s global effort, together with our local work to reduce supply chain packaging and move to reusable solutions that don’t end up in landfill, is something we’re extremely proud of.

For more information about Amgen’s commitment to environmentally responsible operations, visit https://wwwext.amgen.com/responsibility/environmental-sustainability/

Meet Our People

Rachel Gibb and Claire Russell

Head of Corporate Affairs

It was back in 2012 that Rachel Gibb and Claire Russell first approached Amgen Australia about applying for the advertised ‘Head of Corporate Affairs’ position together, as a job-share, and were met with a positive reception. “Amgen’s willingness to explore a job-share spoke volumes about the company’s genuine commitment to diversity and inclusion and, in particular, flexibility,” said Claire. “We were chasing the “holy grail” - the chance to do what we love and to work at a senior level, while still having the chance to be hands on with our kids – and, with Amgen, we found it.” Now, over seven years into their tenure, the pair continue to spearhead Amgen’s corporate, brand and internal communications, together with corporate reputation, advocacy and philanthropy work. It’s a demanding role but the opportunity to combine forces has allowed them to build a strong track record of success locally and contribute to Amgen’s regional and global networks where they’re affectionately known as the “Dynamic Duo.” “When your work is both strategic and creative in nature, having someone you can bounce ideas off makes such a difference. We knew that we had the right chemistry to work together and the kind of mutual trust and respect you need to make a partnership like this successful,” explained Rachel. “Claire and I are grateful that Amgen had the vision to invest in this job-sharing arrangement and we are proud to be an example of how effective it can be,” Rachel said.

Denise McPaul

Senior Biopharmaceutical Representative

As a Senior Biopharmaceutical Representative in Amgen’s oncology team, Denise McPaul is responsible for promoting two of Amgen’s products to medical oncologists. With an extensive background in nursing, and a variety of sales roles under her belt, Denise is passionate about what she does and brings energy and empathy as she works to serve customers and support the needs of patients. “I have a deep knowledge of my therapeutic area and enjoy devising innovative strategies to solve problems and address opportunities that can improve patient outcomes,” Denise said. In 2018, Denise saw an opportunity to improve education about managing a potential side effect of one of her products, so that persistence with treatment was not compromised. “I wanted to offer my customers more definitive advice and introduce them to effective management strategies,” she said. Denise skilfully led a project to develop the material for a dedicated in-service, shared it with her customers and mentored her colleagues around Australia on how they could utilise it too. The information is now frequently used with oncologists, trainees, nurses and pharmacists and is making a significant difference for patients. Denise’s outstanding sales results and wider achievements in oncology saw her receive Amgen’s top sales performance award in 2018.

RECENT JOB OPPORTUNITIES

Job ID Job Title Location Posted Date

No positions available at this time. Please continue to check back.